RAP 3.57% 14.5¢ resapp health limited

yeah. because if the U.S Trials were finished it would be going...

  1. 120 Posts.
    yeah. because if the U.S Trials were finished it would be going into an extended trading halt. And its too early for them to be completed. Its also too early to be saying they are extending the trials. So most likely the Aus trials. Its a bit vague with how they just said clinical trials update...
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.